| Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis JD Anderson, KH Bagamian, F Muhib, MP Amaya, LA Laytner, T Wierzba, ... The Lancet Global Health 7 (3), e321-e330, 2019 | 106 | 2019 |
| Strengthening the argument for rapid brain MR imaging: estimation of reduction in lifetime attributable risk of developing fatal cancer in children with shunted hydrocephalus … K Koral, T Blackburn, AA Bailey, KM Koral, J Anderson American journal of neuroradiology 33 (10), 1851-1854, 2012 | 78 | 2012 |
| Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness R Rheingans, D Atherly, J Anderson Vaccine 30, A15-A23, 2012 | 69 | 2012 |
| The association between domestic animal presence and ownership and household drinking water contamination among peri-urban communities of Kisumu, Kenya AN Barnes, JD Anderson, J Mumma, ZH Mahmud, O Cumming PloS one 13 (6), e0197587, 2018 | 51 | 2018 |
| Measuring disparities in sanitation access: does the measure matter? R Rheingans, JD Anderson, R Luyendijk, O Cumming Tropical Medicine & International Health 19 (1), 2-13, 2014 | 46 | 2014 |
| Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low-and lower middle-income countries JD Anderson IV, KH Bagamian, F Muhib, R Baral, LA Laytner, M Amaya, ... Vaccine: X 2, 100024, 2019 | 36 | 2019 |
| Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk … KH Bagamian, JD Anderson, F Muhib, O Cumming, LA Laytner, ... The Lancet Global Health 8 (1), e101-e112, 2020 | 31 | 2020 |
| Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities R Rheingans, JD Anderson IV, B Anderson, P Chakraborty, D Atherly, ... Vaccine 32, A140-A150, 2014 | 30 | 2014 |
| Estimating inequities in sanitation-related disease burden and estimating the potential impacts of pro-poor targeting R Rheingans, O Cumming, J Anderson, J Showalter London: SHARE: Sanitation and Hygiene Applied Research for Equity, 2012 | 29 | 2012 |
| Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan R Rheingans, JD Anderson IV, KH Bagamian, LA Laytner, CJ Pecenka, ... Vaccine 36 (51), 7780-7789, 2018 | 22 | 2018 |
| High-resolution spatial distribution and estimation of access to improved sanitation in Kenya P Jia, JD Anderson, M Leitner, R Rheingans PLoS One 11 (7), e0158490, 2016 | 22 | 2016 |
| Systematic review of the economic value of diarrheal vaccines R Rheingans, M Amaya, J Anderson, P Chakraborty, J Atem Human vaccines & immunotherapeutics 10 (6), 1582-1594, 2014 | 22 | 2014 |
| The safe start trial to assess the effect of an infant hygiene intervention on enteric infections and diarrhoea in low-income informal neighbourhoods of Kisumu, Kenya: a study … J Mumma, S Simiyu, E Aseyo, J Anderson, A Czerniewska, E Allen, ... BMC infectious diseases 19, 1-11, 2019 | 18 | 2019 |
| Interlocking Inequalities Related to Water and Sanitation, Nutrition and Healthcare Access O Cumming, J Anderson Equality in Water and Sanitation Services, 212-231, 2018 | 16* | 2018 |
| Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People’s Democratic Republic R Rheingans, JD Anderson IV, KH Bagamian, CJ Pecenka Vaccine 36 (51), 7868-7877, 2018 | 14 | 2018 |
| Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria JD Anderson IV, CJ Pecenka, KH Bagamian, RD Rheingans PLoS One 15 (5), e0232941, 2020 | 11 | 2020 |
| Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries JD Anderson IV, F Muhib, R Rheingans, T Wierzba Vaccine: X 3, 100043, 2019 | 10 | 2019 |
| Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study JD Anderson, KH Bagamian, CJ Pecenka, F Muhib, CA Puett, ... The Lancet Global Health 11 (6), e880-e891, 2023 | 9 | 2023 |
| Environmental and behavioural exposure pathways associated with diarrhoea and enteric pathogen detection in 5-month-old, periurban Kenyan infants: a cross-sectional study KK Baker, JAO Mumma, S Simiyu, D Sewell, K Tsai, JD Anderson, ... BMJ open 12 (10), e059878, 2022 | 9 | 2022 |
| Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study C Puett, JD Anderson, KH Bagamian, F Muhib, S Scheele, WP Hausdorff, ... The Lancet Global Health 11 (6), e892-e902, 2023 | 7 | 2023 |
Richard RheingansProfessor of Sustainable Development, Appalachian State UniversityVerified email at appstate.edu
